Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity
Identifieur interne : 003177 ( Main/Exploration ); précédent : 003176; suivant : 003178Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity
Auteurs : S. Shichijo [Japon] ; N. Keicho [Japon] ; H. T. Long [Viêt Nam] ; T. Quy [Viêt Nam] ; N. C. Phi [Viêt Nam] ; L. D. Ha [Viêt Nam] ; V. V. Ban [Viêt Nam] ; S. Itoyama [Japon] ; C. Hu [Taïwan] ; N. Komatsu [Japon] ; T. Kirikae [Japon] ; F. Kirikae [Japon] ; S. Shirasawa [Japon] ; M. Kaji [Japon] ; T. Fukuda [Japon] ; M. Sata [Japon] ; T. Kuratsuji [Japon] ; K. Itoh [Japon] ; T. Sasazuki [Japon]Source :
- Tissue Antigens [ 0001-2815 ] ; 2004-11.
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Immunité, Peptides, Système immunitaire, Sérum, Virus du SRAS.
- sang : Immunoglobuline G.
- Humains, Rhéologie, Test ELISA.
English descriptors
- KwdEn :
- MESH :
- chemical , blood : Immunoglobulin G.
- immunology : Immune System, Immunity, Peptides, SARS Virus, Serum.
- Teeft :
- Absorption test, Clin chem, Clinical manifestations, Contact persons, Coronavirus, Corresponding peptide, Dose dependency, Elisa, Enzyme-Linked Immunosorbent Assay, Epitope, Flowmetry analysis, Fluorescence intensity, Fluorescence intensity fluorescence intensity, Fluorescence intensity patient, Giai phong, Healthy donors, Higher levels, Humans, Humoral responses, Immunogenic, Immunogenic epitopes, Immunogenic regions, Japanese patients, Kinetic studies, Kurume, Kurume university school, Luminex, Luminex corp, Luminex reactivities, Negative controls, None peptides, Novel coronavirus, Nucleocapsid, Nucleocapsid protein, Peptide, Peptide peptide sequence, Plate shaker, Positions peptide, Protective vaccine, Reactive, Representative results, Respiratory syndrome, Respiratory syndrome coronavirus, Rheology, Rheumatoid arthritis, Room temperature, Saan district, Same times, Sars, Sars patients, Sars peptides, Serum dilution, Serum samples, Shichijo, Significant levels, Syndrome, Synthetic peptides, Systemic lupus erythematosus, Taiwanese patients, Times dilution, Tissue antigens, Vaccine.
Abstract
Abstract: In order to determine highly immunogenic severe acute respiratory syndrome coronavirus (SARS‐CoV) epitope peptides capable of inducing long‐lasting immunity, we first screened immunoglobulin‐G (IgG) antibodies reactive to 197 different overlapping 15‐mers from the SARS‐CoV proteins in the sera of three infected patients. Forty‐two peptides among them were reactive to the sera from all three patients. Consequently, we tested for the reactivity of these 42 peptides to patients' sera (n = 45) at 6‐month post‐infection. The significantly higher levels of IgG antibodies specific to three (S791, M207 and N161) of 42 peptides were detectable in the post‐infection sera from 23 (51%), 27 (60%) and 19 (42%) of 45 patients, respectively. These three peptides, recognized by their long‐lasting immunity, may provide a better understanding of the immunogenicity of SARS‐CoV.
Url:
DOI: 10.1111/j.1399-0039.2004.00314.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000763
- to stream Istex, to step Curation: 000763
- to stream Istex, to step Checkpoint: 000C35
- to stream PubMed, to step Corpus: 002364
- to stream PubMed, to step Curation: 002364
- to stream PubMed, to step Checkpoint: 002283
- to stream Ncbi, to step Merge: 000311
- to stream Ncbi, to step Curation: 000311
- to stream Ncbi, to step Checkpoint: 000311
- to stream Main, to step Merge: 003209
- to stream Main, to step Curation: 003177
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity</title>
<author><name sortKey="Shichijo, S" sort="Shichijo, S" uniqKey="Shichijo S" first="S." last="Shichijo">S. Shichijo</name>
</author>
<author><name sortKey="Keicho, N" sort="Keicho, N" uniqKey="Keicho N" first="N." last="Keicho">N. Keicho</name>
</author>
<author><name sortKey="Long, H T" sort="Long, H T" uniqKey="Long H" first="H. T." last="Long">H. T. Long</name>
</author>
<author><name sortKey="Quy, T" sort="Quy, T" uniqKey="Quy T" first="T." last="Quy">T. Quy</name>
</author>
<author><name sortKey="Phi, N C" sort="Phi, N C" uniqKey="Phi N" first="N. C." last="Phi">N. C. Phi</name>
</author>
<author><name sortKey="Ha, L D" sort="Ha, L D" uniqKey="Ha L" first="L. D." last="Ha">L. D. Ha</name>
</author>
<author><name sortKey="Ban, V V" sort="Ban, V V" uniqKey="Ban V" first="V. V." last="Ban">V. V. Ban</name>
</author>
<author><name sortKey="Itoyama, S" sort="Itoyama, S" uniqKey="Itoyama S" first="S." last="Itoyama">S. Itoyama</name>
</author>
<author><name sortKey="Hu, C" sort="Hu, C" uniqKey="Hu C" first="C." last="Hu">C. Hu</name>
</author>
<author><name sortKey="Komatsu, N" sort="Komatsu, N" uniqKey="Komatsu N" first="N." last="Komatsu">N. Komatsu</name>
</author>
<author><name sortKey="Kirikae, T" sort="Kirikae, T" uniqKey="Kirikae T" first="T." last="Kirikae">T. Kirikae</name>
</author>
<author><name sortKey="Kirikae, F" sort="Kirikae, F" uniqKey="Kirikae F" first="F." last="Kirikae">F. Kirikae</name>
</author>
<author><name sortKey="Shirasawa, S" sort="Shirasawa, S" uniqKey="Shirasawa S" first="S." last="Shirasawa">S. Shirasawa</name>
</author>
<author><name sortKey="Kaji, M" sort="Kaji, M" uniqKey="Kaji M" first="M." last="Kaji">M. Kaji</name>
</author>
<author><name sortKey="Fukuda, T" sort="Fukuda, T" uniqKey="Fukuda T" first="T." last="Fukuda">T. Fukuda</name>
</author>
<author><name sortKey="Sata, M" sort="Sata, M" uniqKey="Sata M" first="M." last="Sata">M. Sata</name>
</author>
<author><name sortKey="Kuratsuji, T" sort="Kuratsuji, T" uniqKey="Kuratsuji T" first="T." last="Kuratsuji">T. Kuratsuji</name>
</author>
<author><name sortKey="Itoh, K" sort="Itoh, K" uniqKey="Itoh K" first="K." last="Itoh">K. Itoh</name>
</author>
<author><name sortKey="Sasazuki, T" sort="Sasazuki, T" uniqKey="Sasazuki T" first="T." last="Sasazuki">T. Sasazuki</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0144A752526A448C35F9BF8FE17D22DA1834C23D</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1111/j.1399-0039.2004.00314.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-3462P0ZW-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000763</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000763</idno>
<idno type="wicri:Area/Istex/Curation">000763</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C35</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C35</idno>
<idno type="wicri:doubleKey">0001-2815:2004:Shichijo S:assessment:of:synthetic</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15496204</idno>
<idno type="wicri:Area/PubMed/Corpus">002364</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002364</idno>
<idno type="wicri:Area/PubMed/Curation">002364</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002364</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002283</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002283</idno>
<idno type="wicri:Area/Ncbi/Merge">000311</idno>
<idno type="wicri:Area/Ncbi/Curation">000311</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000311</idno>
<idno type="wicri:doubleKey">0001-2815:2004:Shichijo S:assessment:of:synthetic</idno>
<idno type="wicri:Area/Main/Merge">003209</idno>
<idno type="wicri:Area/Main/Curation">003177</idno>
<idno type="wicri:Area/Main/Exploration">003177</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity</title>
<author><name sortKey="Shichijo, S" sort="Shichijo, S" uniqKey="Shichijo S" first="S." last="Shichijo">S. Shichijo</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Immunology, Kurume University School of Medicine, Asahi‐machi, Kurume, Fukuoka</wicri:regionArea>
<wicri:noRegion>Fukuoka</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Keicho, N" sort="Keicho, N" uniqKey="Keicho N" first="N." last="Keicho">N. Keicho</name>
<affiliation wicri:level="3"><country xml:lang="fr">Japon</country>
<wicri:regionArea>International Medical Center of Japan, Toyama, Shinjuku, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Long, H T" sort="Long, H T" uniqKey="Long H" first="H. T." last="Long">H. T. Long</name>
<affiliation wicri:level="1"><country xml:lang="fr">Viêt Nam</country>
<wicri:regionArea>National Institute of Hygiene and Epidemiology, Yersin, Hanoi</wicri:regionArea>
<wicri:noRegion>Hanoi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Quy, T" sort="Quy, T" uniqKey="Quy T" first="T." last="Quy">T. Quy</name>
<affiliation wicri:level="1"><country xml:lang="fr">Viêt Nam</country>
<wicri:regionArea>Bach Mai Hospital, Giai Phong, Hanoi</wicri:regionArea>
<wicri:noRegion>Hanoi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Phi, N C" sort="Phi, N C" uniqKey="Phi N" first="N. C." last="Phi">N. C. Phi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Viêt Nam</country>
<wicri:regionArea>Bach Mai Hospital, Giai Phong, Hanoi</wicri:regionArea>
<wicri:noRegion>Hanoi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ha, L D" sort="Ha, L D" uniqKey="Ha L" first="L. D." last="Ha">L. D. Ha</name>
<affiliation wicri:level="1"><country xml:lang="fr">Viêt Nam</country>
<wicri:regionArea>Institute for Clinical Research in Tropical Medicine, Bach Mai Hospital, Giai Phong, Hanoi</wicri:regionArea>
<wicri:noRegion>Hanoi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ban, V V" sort="Ban, V V" uniqKey="Ban V" first="V. V." last="Ban">V. V. Ban</name>
<affiliation wicri:level="1"><country xml:lang="fr">Viêt Nam</country>
<wicri:regionArea>Hanoi French Hospital, Phuong Mai, Hanoi</wicri:regionArea>
<wicri:noRegion>Hanoi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Itoyama, S" sort="Itoyama, S" uniqKey="Itoyama S" first="S." last="Itoyama">S. Itoyama</name>
<affiliation wicri:level="3"><country xml:lang="fr">Japon</country>
<wicri:regionArea>International Medical Center of Japan, Toyama, Shinjuku, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hu, C" sort="Hu, C" uniqKey="Hu C" first="C." last="Hu">C. Hu</name>
<affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Taipei Municipal Jen‐Ai Hospital, SaAn District, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Komatsu, N" sort="Komatsu, N" uniqKey="Komatsu N" first="N." last="Komatsu">N. Komatsu</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Immunology, Kurume University School of Medicine, Asahi‐machi, Kurume, Fukuoka</wicri:regionArea>
<wicri:noRegion>Fukuoka</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kirikae, T" sort="Kirikae, T" uniqKey="Kirikae T" first="T." last="Kirikae">T. Kirikae</name>
<affiliation wicri:level="3"><country xml:lang="fr">Japon</country>
<wicri:regionArea>International Medical Center of Japan, Toyama, Shinjuku, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kirikae, F" sort="Kirikae, F" uniqKey="Kirikae F" first="F." last="Kirikae">F. Kirikae</name>
<affiliation wicri:level="3"><country xml:lang="fr">Japon</country>
<wicri:regionArea>International Medical Center of Japan, Toyama, Shinjuku, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shirasawa, S" sort="Shirasawa, S" uniqKey="Shirasawa S" first="S." last="Shirasawa">S. Shirasawa</name>
<affiliation wicri:level="3"><country xml:lang="fr">Japon</country>
<wicri:regionArea>International Medical Center of Japan, Toyama, Shinjuku, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kaji, M" sort="Kaji, M" uniqKey="Kaji M" first="M." last="Kaji">M. Kaji</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Kurume Medical Center, Kokubu‐machi, Kurume</wicri:regionArea>
<wicri:noRegion>Kurume</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fukuda, T" sort="Fukuda, T" uniqKey="Fukuda T" first="T." last="Fukuda">T. Fukuda</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Kurume Medical Center, Kokubu‐machi, Kurume</wicri:regionArea>
<wicri:noRegion>Kurume</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sata, M" sort="Sata, M" uniqKey="Sata M" first="M." last="Sata">M. Sata</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Internal Medicine, Kurume University School of Medicine, Asahi‐machi, Kurume, Fukuoka</wicri:regionArea>
<wicri:noRegion>Fukuoka</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kuratsuji, T" sort="Kuratsuji, T" uniqKey="Kuratsuji T" first="T." last="Kuratsuji">T. Kuratsuji</name>
<affiliation wicri:level="3"><country xml:lang="fr">Japon</country>
<wicri:regionArea>International Medical Center of Japan, Toyama, Shinjuku, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Itoh, K" sort="Itoh, K" uniqKey="Itoh K" first="K." last="Itoh">K. Itoh</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Immunology, Kurume University School of Medicine, Asahi‐machi, Kurume, Fukuoka</wicri:regionArea>
<wicri:noRegion>Fukuoka</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sasazuki, T" sort="Sasazuki, T" uniqKey="Sasazuki T" first="T." last="Sasazuki">T. Sasazuki</name>
<affiliation wicri:level="3"><country xml:lang="fr">Japon</country>
<wicri:regionArea>International Medical Center of Japan, Toyama, Shinjuku, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Correspondence address: *T. SasazukiInternational Medical Center of Japan, Toyama, Shinjuku, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Tissue Antigens</title>
<title level="j" type="alt">TISSUE ANTIGENS</title>
<idno type="ISSN">0001-2815</idno>
<idno type="eISSN">1399-0039</idno>
<imprint><biblScope unit="vol">64</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="600">600</biblScope>
<biblScope unit="page" to="607">607</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Munksgaard International Publishers</publisher>
<pubPlace>Oxford, UK; Malden, USA</pubPlace>
<date type="published" when="2004-11">2004-11</date>
</imprint>
<idno type="ISSN">0001-2815</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0001-2815</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Enzyme-Linked Immunosorbent Assay</term>
<term>Humans</term>
<term>Immune System (immunology)</term>
<term>Immunity (immunology)</term>
<term>Immunoglobulin G (blood)</term>
<term>Peptides (immunology)</term>
<term>Rheology</term>
<term>SARS Virus (immunology)</term>
<term>Serum (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Humains</term>
<term>Immunité (immunologie)</term>
<term>Immunoglobuline G (sang)</term>
<term>Peptides (immunologie)</term>
<term>Rhéologie</term>
<term>Système immunitaire (immunologie)</term>
<term>Sérum (immunologie)</term>
<term>Test ELISA</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Immunoglobulin G</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Immunité</term>
<term>Peptides</term>
<term>Système immunitaire</term>
<term>Sérum</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Immune System</term>
<term>Immunity</term>
<term>Peptides</term>
<term>SARS Virus</term>
<term>Serum</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Immunoglobuline G</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Absorption test</term>
<term>Clin chem</term>
<term>Clinical manifestations</term>
<term>Contact persons</term>
<term>Coronavirus</term>
<term>Corresponding peptide</term>
<term>Dose dependency</term>
<term>Elisa</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Epitope</term>
<term>Flowmetry analysis</term>
<term>Fluorescence intensity</term>
<term>Fluorescence intensity fluorescence intensity</term>
<term>Fluorescence intensity patient</term>
<term>Giai phong</term>
<term>Healthy donors</term>
<term>Higher levels</term>
<term>Humans</term>
<term>Humoral responses</term>
<term>Immunogenic</term>
<term>Immunogenic epitopes</term>
<term>Immunogenic regions</term>
<term>Japanese patients</term>
<term>Kinetic studies</term>
<term>Kurume</term>
<term>Kurume university school</term>
<term>Luminex</term>
<term>Luminex corp</term>
<term>Luminex reactivities</term>
<term>Negative controls</term>
<term>None peptides</term>
<term>Novel coronavirus</term>
<term>Nucleocapsid</term>
<term>Nucleocapsid protein</term>
<term>Peptide</term>
<term>Peptide peptide sequence</term>
<term>Plate shaker</term>
<term>Positions peptide</term>
<term>Protective vaccine</term>
<term>Reactive</term>
<term>Representative results</term>
<term>Respiratory syndrome</term>
<term>Respiratory syndrome coronavirus</term>
<term>Rheology</term>
<term>Rheumatoid arthritis</term>
<term>Room temperature</term>
<term>Saan district</term>
<term>Same times</term>
<term>Sars</term>
<term>Sars patients</term>
<term>Sars peptides</term>
<term>Serum dilution</term>
<term>Serum samples</term>
<term>Shichijo</term>
<term>Significant levels</term>
<term>Syndrome</term>
<term>Synthetic peptides</term>
<term>Systemic lupus erythematosus</term>
<term>Taiwanese patients</term>
<term>Times dilution</term>
<term>Tissue antigens</term>
<term>Vaccine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Rhéologie</term>
<term>Test ELISA</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: In order to determine highly immunogenic severe acute respiratory syndrome coronavirus (SARS‐CoV) epitope peptides capable of inducing long‐lasting immunity, we first screened immunoglobulin‐G (IgG) antibodies reactive to 197 different overlapping 15‐mers from the SARS‐CoV proteins in the sera of three infected patients. Forty‐two peptides among them were reactive to the sera from all three patients. Consequently, we tested for the reactivity of these 42 peptides to patients' sera (n = 45) at 6‐month post‐infection. The significantly higher levels of IgG antibodies specific to three (S791, M207 and N161) of 42 peptides were detectable in the post‐infection sera from 23 (51%), 27 (60%) and 19 (42%) of 45 patients, respectively. These three peptides, recognized by their long‐lasting immunity, may provide a better understanding of the immunogenicity of SARS‐CoV.</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
<li>Taïwan</li>
<li>Viêt Nam</li>
</country>
<region><li>Région de Kantō</li>
</region>
<settlement><li>Tokyo</li>
</settlement>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Shichijo, S" sort="Shichijo, S" uniqKey="Shichijo S" first="S." last="Shichijo">S. Shichijo</name>
</noRegion>
<name sortKey="Fukuda, T" sort="Fukuda, T" uniqKey="Fukuda T" first="T." last="Fukuda">T. Fukuda</name>
<name sortKey="Itoh, K" sort="Itoh, K" uniqKey="Itoh K" first="K." last="Itoh">K. Itoh</name>
<name sortKey="Itoyama, S" sort="Itoyama, S" uniqKey="Itoyama S" first="S." last="Itoyama">S. Itoyama</name>
<name sortKey="Kaji, M" sort="Kaji, M" uniqKey="Kaji M" first="M." last="Kaji">M. Kaji</name>
<name sortKey="Keicho, N" sort="Keicho, N" uniqKey="Keicho N" first="N." last="Keicho">N. Keicho</name>
<name sortKey="Kirikae, F" sort="Kirikae, F" uniqKey="Kirikae F" first="F." last="Kirikae">F. Kirikae</name>
<name sortKey="Kirikae, T" sort="Kirikae, T" uniqKey="Kirikae T" first="T." last="Kirikae">T. Kirikae</name>
<name sortKey="Komatsu, N" sort="Komatsu, N" uniqKey="Komatsu N" first="N." last="Komatsu">N. Komatsu</name>
<name sortKey="Kuratsuji, T" sort="Kuratsuji, T" uniqKey="Kuratsuji T" first="T." last="Kuratsuji">T. Kuratsuji</name>
<name sortKey="Sasazuki, T" sort="Sasazuki, T" uniqKey="Sasazuki T" first="T." last="Sasazuki">T. Sasazuki</name>
<name sortKey="Sasazuki, T" sort="Sasazuki, T" uniqKey="Sasazuki T" first="T." last="Sasazuki">T. Sasazuki</name>
<name sortKey="Sata, M" sort="Sata, M" uniqKey="Sata M" first="M." last="Sata">M. Sata</name>
<name sortKey="Shirasawa, S" sort="Shirasawa, S" uniqKey="Shirasawa S" first="S." last="Shirasawa">S. Shirasawa</name>
</country>
<country name="Viêt Nam"><noRegion><name sortKey="Long, H T" sort="Long, H T" uniqKey="Long H" first="H. T." last="Long">H. T. Long</name>
</noRegion>
<name sortKey="Ban, V V" sort="Ban, V V" uniqKey="Ban V" first="V. V." last="Ban">V. V. Ban</name>
<name sortKey="Ha, L D" sort="Ha, L D" uniqKey="Ha L" first="L. D." last="Ha">L. D. Ha</name>
<name sortKey="Phi, N C" sort="Phi, N C" uniqKey="Phi N" first="N. C." last="Phi">N. C. Phi</name>
<name sortKey="Quy, T" sort="Quy, T" uniqKey="Quy T" first="T." last="Quy">T. Quy</name>
</country>
<country name="Taïwan"><noRegion><name sortKey="Hu, C" sort="Hu, C" uniqKey="Hu C" first="C." last="Hu">C. Hu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003177 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003177 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:0144A752526A448C35F9BF8FE17D22DA1834C23D |texte= Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity }}
This area was generated with Dilib version V0.6.33. |